A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Chroma Dex Corp. stock. As of the latest transaction made, Renaissance Technologies LLC holds 424,200 shares of CDXC stock, worth $3.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
424,200
Previous 416,100 1.95%
Holding current value
$3.24 Million
Previous $1.14 Million 36.39%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.51 - $3.8 $20,331 - $30,780
8,100 Added 1.95%
424,200 $1.55 Million
Q2 2024

Aug 09, 2024

BUY
$2.44 - $4.32 $79,056 - $139,968
32,400 Added 8.44%
416,100 $1.14 Million
Q1 2024

May 13, 2024

SELL
$1.36 - $3.84 $116,418 - $328,711
-85,602 Reduced 18.24%
383,700 $1.34 Million
Q4 2023

Feb 13, 2024

BUY
$1.28 - $1.6 $31,219 - $39,024
24,390 Added 5.48%
469,302 $671,000
Q3 2023

Nov 14, 2023

SELL
$1.36 - $1.77 $21,252 - $27,659
-15,627 Reduced 3.39%
444,912 $650,000
Q2 2023

Aug 11, 2023

BUY
$1.31 - $1.79 $43,674 - $59,676
33,339 Added 7.8%
460,539 $723,000
Q1 2023

May 12, 2023

SELL
$1.48 - $2.19 $212,676 - $314,703
-143,700 Reduced 25.17%
427,200 $654,000
Q4 2022

Feb 13, 2023

SELL
$1.25 - $1.94 $59,137 - $91,781
-47,310 Reduced 7.65%
570,900 $959,000
Q3 2022

Nov 14, 2022

SELL
$1.19 - $2.06 $144,811 - $250,681
-121,690 Reduced 16.45%
618,210 $760,000
Q2 2022

Aug 12, 2022

BUY
$1.59 - $2.7 $507,844 - $862,377
319,399 Added 75.96%
739,900 $1.24 Million
Q1 2022

May 13, 2022

BUY
$2.02 - $3.92 $772,474 - $1.5 Million
382,413 Added 1004.02%
420,501 $1.03 Million
Q4 2021

Feb 11, 2022

BUY
$3.74 - $6.7 $142,449 - $255,189
38,088 New
38,088 $142,000
Q1 2021

May 13, 2021

SELL
$4.59 - $18.74 $1.08 Million - $4.41 Million
-235,200 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$3.93 - $5.5 $604,508 - $846,004
153,819 Added 189.01%
235,200 $1.13 Million
Q3 2020

Nov 13, 2020

SELL
$4.01 - $5.56 $516,564 - $716,233
-128,819 Reduced 61.28%
81,381 $326,000
Q2 2020

Aug 13, 2020

BUY
$3.0 - $5.52 $630,600 - $1.16 Million
210,200 New
210,200 $965,000
Q4 2019

Feb 13, 2020

SELL
$2.83 - $4.61 $112,917 - $183,939
-39,900 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$3.83 - $4.72 $152,817 - $188,328
39,900 New
39,900 $157,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $522M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.